Unique ID issued by UMIN | UMIN000019027 |
---|---|
Receipt number | R000022000 |
Scientific Title | Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case |
Date of disclosure of the study information | 2015/09/15 |
Last modified on | 2019/06/24 09:23:12 |
Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case
Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case
Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case
Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case
Japan |
Massive hemorrhage by trauma, gastrointestinal hemorrhage
Surgery in general | Gastrointestinal surgery | Operative medicine |
Emergency medicine | Blood transfusion |
Others
NO
To examine the effect of the dosage of the concentrated fibrinogen preparation as supportive treatment for the patients who are expected that a large amount of blood transfusins are required because of massive hemorrage.
Safety,Efficacy
The amount of total blood tranfusion until hemostasis completion
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
Term:28 weeks
infusion:Red cell concentrated 10units, ordinary blood transfusion concentrated fibrin preparation 3g
Term:28 weeks
infusion:Red cell concentrated 10units, ordinary blood transfusion
20 | years-old | <= |
Not applicable |
Male and Female
1.The man and woman who are 20 years or older.
2.The patients that doctor recognizes necessity of massive blood transfusin by MTP due to massive hemorrhage by injury and gastrointestinal bleeding.
3.The patients who are conveyed and admitted to emergency and critical care center, without tranferring to the other hospital and Obstetrics,
heart blood vessel sugeryy patient
1.Pregnant woman
2.Under 20 years old
3.Immunocompromised (state) patients
4.Patients with allegy for blood products
5.Patients who are diagnosed as congenital low fibrinogen blood symptom
6.the patient that informed consent is not provided
7.the patient who is dead during primary care treatment even MTP procedure was exercised or not given the treatment with RCC,FFP and the concentrated fibrin preparation.
8.the patient who cannot perform a blood test after dosage
70
1st name | Yasuhiro |
Middle name | |
Last name | Otomo |
Medical Hospital,Tokyo Medical and Dental University
Trauma and Acute Critical Care Medical Center
113-8510
1-5-45 Yushima Bunkyo-ku Tokyo
03-3813-6111
otomo.accm@tmd.ac.jp
1st name | Kiyoshi |
Middle name | |
Last name | Murata |
Medical Hospital,Tokyo Medical and Dental University
Trauma and Acute Critical Care Medical Center
113-8510
1-5-45 Yushima Bunkyo-ku Tokyo
03-3813-6111
murata.acc@tmd.ac.jp
Trauma and Acute Critical Care Medical Center,Medical Hospital,Tokyo Medical and Dental Universitiy
Tokyo Medical and Dental University
Self funding
Clinical Research Review Board TMDU Medical Hospitale
1-5-45,Yushima, BUnkyo-ward,Tokyo,Japan
03-3813-6111
03-3813-6111
NO
2015 | Year | 09 | Month | 15 | Day |
Unpublished
Open public recruiting
2013 | Year | 10 | Month | 31 | Day |
2013 | Year | 12 | Month | 17 | Day |
2014 | Year | 01 | Month | 10 | Day |
2020 | Year | 12 | Month | 31 | Day |
2015 | Year | 09 | Month | 15 | Day |
2019 | Year | 06 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022000